Got A Tip?

Star Seeker

Avril Lavigne

Avril Lavigne Was In Bed 'For Two F**king Years' During Lyme Disease Battle

Avril Lavigne lyme disease praying

Where has Avril Lavigne been the past few years, you ask? In bed, crippled by her Lyme disease. 
The 34-year-old singer got candid about her health battle and upcoming comeback album in a new interview with Billboard, revealing that she was “in bed for f**king two years” while doctors were trying to kill the literal bug inside of her.
Video: Avril Goes FULL Celine For ‘Head Above Water’!
Yes, Lyme disease, as Avril explained to the mag, is “a bug — a spirochete — so you take these antibiotics, and they start killing it.” She then added:

“But it’s a smart bug: It morphs into a cystic form, so you have to take other antibiotics at the same time. It went undiagnosed for so long that I was kind of f**ked.”

The Complicated pop rocker’s situation got worse. Eventually, she was bedridden and unable to breathe — so, she started to pray:

“I had accepted that I was dying. And I felt in that moment like I was underwater and drowning, and I was trying to come up to gasp for air. And literally under my breath, I was like, ‘God, help me keep my head above the water.'”

Not only did it work, but that little prayer became the inspiration for her song Head Above Water, which she dropped last month after a five year hiatus from music.
The disease may have nearly killed her, but Avril says it wasn’t all bad:

“The silver lining of it is that I’ve really had the time to be able to just be present, instead of being, like, a machine: studio, tour, studio, tour. This is the first break I’ve ever taken since I was 15.”

We’re glad she’s back to work!
See how healthy she looks in her Billboard spread (below)!

View this post on Instagram

#AvrilOnBillboard | ????: @david_needleman

A post shared by Billboard (@billboard) on

View this post on Instagram

#AvrilOnBillboard | ????: @david_needleman

A post shared by Billboard (@billboard) on

[Image via Instagram.]

Related Posts

CLICK HERE TO COMMENT
Oct 19, 2018 04:30am PDT